ESOPHAGEAL SQUAMOUS CELL CARCINOMAS
Clinical trials for ESOPHAGEAL SQUAMOUS CELL CARCINOMAS explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGEAL SQUAMOUS CELL CARCINOMAS trials appear
Sign up with your email to follow new studies for ESOPHAGEAL SQUAMOUS CELL CARCINOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for hard-to-treat esophageal cancer?
Disease control OngoingThis study tests a combination of two drugs, SI-B001 and irinotecan, in people with advanced esophageal cancer that has come back or spread and no longer responds to standard treatments. The goal is to see if the combo can shrink tumors and how safe it is. About 22 adults aged 18…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMAS
Phase: PHASE2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 09:35 UTC
-
New combo therapy shows promise for tough esophageal cancer
Disease control OngoingThis study tests whether giving immunotherapy plus chemotherapy before the usual chemoradiation can help people with advanced esophageal cancer that cannot be surgically removed. About 50 adults with this type of cancer will receive the combination treatment, then chemoradiation.…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMAS
Phase: PHASE2 • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated May 20, 2026 11:54 UTC